Evidence map›Paper›PMID 35844682›Full record

ArticleEJHaem2021

Applicability of Western protocols in resource-limited setting: Real-world data of long-term outcome of intensive treatment of adult acute myeloid leukaemia in Sri Lanka.

Saman Hewamana, Lakmali Kandabadage, Thurairajah Skandarajah, Natasha Pieris, Eranga Perera, Mahesh Harischandra, Ananda Wijewickrama, Chandana Wickramarathna, Gnani Somasundaram, Vadivelu Srinivasan and 10 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in EJHaem, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Saman HewamanaClinical Haematology Unit Lanka Hospitals Colombo Sri Lanka.ORCID https://orcid.org/0000-0002-5439-8398
Lakmali KandabadageClinical Haematology Unit Lanka Hospitals Colombo Sri Lanka.
Thurairajah SkandarajahNational Cancer Institute Colombo Sri Lanka.
Natasha PierisAsiri Surgical Hospital Colombo Sri Lanka.
Eranga PereraAsiri Surgical Hospital Colombo Sri Lanka.
Mahesh HarischandraLanka Hospitals Colombo Sri Lanka.
Ananda WijewickramaNational Institute of Infectious Disease Angoda Sri Lanka.
Chandana WickramarathnaFaculty of Medicine University of Ruhuna Matara Sri Lanka.
Gnani SomasundaramLanka Hospitals Colombo Sri Lanka.
Vadivelu SrinivasanLanka Hospitals Colombo Sri Lanka.
Surjit SomiahLanka Hospitals Colombo Sri Lanka.
Priyankara JayawardenaNational Hospital of Sri Lanka Colombo Sri Lanka.
Mehendra PereraNational Cancer Institute Colombo Sri Lanka.
Dehan GunasekeraNational Cancer Institute Colombo Sri Lanka.
Chathuri JayasingheUniversity of Sri Jayewardenepura Colombo Sri Lanka.
Godvin ConstantineNational Hospital of Sri Lanka Colombo Sri Lanka.
Sanjeewa MunasingheArmy Hospital Colombo Sri Lanka.
Chandu De SilvaFaculty of Medicine University of Colombo Colombo Sri Lanka.
Bandula WijesiriwardenaLanka Hospitals Colombo Sri Lanka.
Jayantha BalawardenaSir John Kotelawala Defence University, Werahera Colombo Sri Lanka.
Lanka Hospitals · LKNational Hospital of Sri Lanka · LKGeneral Sir John Kotelawala Defence University · LKUniversity of Colombo · LKUniversity of Ruhuna · LKUniversity of Sri Jayewardenepura · LK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are no published data on long-term survival and applicability of treatment protocols from developed countries in acute myeloid leukaemia (AML) in Sri Lanka. Eighty-seven AML patients were reviewed; there were 56 newly diagnosed patients between 18 and 65 years. Thirty-one out of 33 who started treatment achieved complete remission after first cycle of treatment. The induction mortality was one of 33. Twelve out of 20 patients who completed treatment are alive at the time of analysis. The estimated 5-year overall survival rate is 0.629. Strict infection control and treatment and superior clinical experience may have contributed towards better outcome.

Indexed as

AMLdeveloping countriesSri Lankasurvival

Identifiers

PMID35844682
PMCPMC9176152
OpenAlexW3163675521

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.